Antibodies to bone morphogenic proteins and receptors therefor and methods for their use

Details for Australian Patent Application No. 2007292890 (hide)

Owner Medarex, Inc.

Inventors LeBlanc, Heidi N.; Sproul, Timothy William; Zimmerman, Deborah; Srinivasan, Mohan; Bell, Alasdair; Zens, Kyra D.; Selby, Mark; Singh, Sujata; Theolis Jr., Richard

Agent Davies Collison Cave

Pub. Number AU-A-2007292890

PCT Pub. Number WO2008/030611

Priority 60/824,596 05.09.06 US

Filing date 5 September 2007

Wipo publication date 13 March 2008

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/16 (2006.01) Mutation or genetic engineering - Hormones

C12N 15/22 (2006.01) Mutation or genetic engineering

C12N 15/24 (2006.01) Mutation or genetic engineering

C12N 15/26 (2006.01) Mutation or genetic engineering

C12N 15/28 (2006.01) Mutation or genetic engineering

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/030611 Priority application(s): WO2008/030611

7 May 2009 Alteration of Name

  The name of the applicant has been altered to Medarex, Inc.; Zimmerman, D.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007292891-Site specific incorporation of nonnatural amino acids by vertebrate cells

2007292883-Treatment, prevention, and reversal of alcohol-induced brain disease